StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Anika Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -3.1%. For fiscal 2025 it was -9.6%, against -47.0% the year before. The highest annual figure on record is 36.3% in fiscal 2014.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-9.6%+37.4
FY2024Dec 31, 2024-47.0%+21.4
FY2023Dec 31, 2023-68.4%−55.4
FY2022Dec 31, 2022-13.1%−15.9
FY2021Dec 31, 20212.8%+21.2
FY2020Dec 31, 2020-18.4%−42.1
FY2019Dec 31, 201923.7%+6.0
FY2018Dec 31, 201817.7%−10.3
FY2017Dec 31, 201728.1%−3.4
FY2016Dec 31, 201631.5%−1.6
FY2015Dec 31, 201533.1%−3.2
FY2014Dec 31, 201436.3%+8.9
FY2013Dec 31, 201327.4%+10.9
FY2012Dec 31, 201216.5%+3.4
FY2011Dec 31, 201113.1%+5.3
FY2010Dec 31, 20107.8%−1.4
FY2009Dec 31, 20099.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202610.1%+24.2
Q1 FY2026Mar 31, 2026-17.1%+1.5
Q4 FY2025Dec 31, 20251.0%+72.4
Q3 FY2025Sep 30, 2025-8.4%+92.8
Q2 FY2025Jun 30, 2025-14.1%−13.8
Q1 FY2025Mar 31, 2025-18.6%−3.1
Q4 FY2024Dec 31, 2024-71.4%+75.2
Q3 FY2024Sep 30, 2024-101.2%−85.4
Q2 FY2024Jun 30, 2024-0.3%+5.9
Q1 FY2024Mar 31, 2024-15.6%+11.7
Q4 FY2023Dec 31, 2023-146.6%−134.2
Q3 FY2023Sep 30, 2023-15.9%−5.5
Q2 FY2023Jun 30, 2023-6.2%+1.0
Q1 FY2023Mar 31, 2023-27.3%−19.3
Q4 FY2022Dec 31, 2022-12.4%+3.8
Q3 FY2022Sep 30, 2022-10.4%−11.8
Q2 FY2022Jun 30, 2022-7.2%−24.3
Q1 FY2022Mar 31, 2022-8.0%−16.3
Q4 FY2021Dec 31, 2021-16.2%+31.7
Q3 FY2021Sep 30, 20211.4%+21.6
Q2 FY2021Jun 30, 202117.1%+42.2
Q1 FY2021Mar 31, 20218.3%−8.1
Q4 FY2020Dec 31, 2020-47.9%−61.5
Q3 FY2020Sep 30, 2020-20.2%−51.2
Q2 FY2020Jun 30, 2020-25.1%−56.1
Q1 FY2020Mar 31, 202016.4%−1.9
Q4 FY2019Dec 31, 201913.6%−15.0
Q3 FY2019Sep 30, 201931.0%+2.6
Q2 FY2019Jun 30, 201931.0%−2.0
Q1 FY2019Mar 31, 201918.2%+49.7
Q4 FY2018Dec 31, 201828.6%+1.2
Q3 FY2018Sep 30, 201828.4%+3.0
Q2 FY2018Jun 30, 201833.0%−0.9
Q1 FY2018Mar 31, 2018-31.4%−54.9
Q4 FY2017Dec 31, 201727.4%−0.7
Q3 FY2017Sep 30, 201725.3%−9.4
Q2 FY2017Jun 30, 201734.0%–
Q1 FY2017Mar 31, 201723.5%–
Q4 FY2016Dec 31, 201628.1%–
Q3 FY2016Sep 30, 201634.7%–

More Anika Therapeutics figures

See a number that looks wrong?